1. Corbin, Laura J, White, Stephen J, Taylor, Amy E, Poole, Alastair W, Timpson, Nicholas J. 2022. Epigenetic Regulation of F2RL3 Associates With Myocardial Infarction and Platelet Function. In Circulation research, 130, 384-400. doi:10.1161/CIRCRESAHA.121.318836. https://pubmed.ncbi.nlm.nih.gov/35012325/
2. Zhao, Xiaojing, Zhu, Liya, Yin, Qiming, Yang, Rongxi, He, Kunlun. 2022. F2RL3 Methylation in the Peripheral Blood as a Potential Marker for the Detection of Coronary Heart Disease: A Case-Control Study. In Frontiers in genetics, 13, 833923. doi:10.3389/fgene.2022.833923. https://pubmed.ncbi.nlm.nih.gov/35419024/
3. Ma, Jun, Shi, Yongkang, Lu, Qiliang, Huang, Dongsheng. . F2RL3 Regulates Epithelial-Mesenchymal Transition and Angiogenesis in Gastric Cancer through the Rap1/MAPK Signaling Pathway. In Frontiers in bioscience (Landmark edition), 29, 177. doi:10.31083/j.fbl2905177. https://pubmed.ncbi.nlm.nih.gov/38812308/
4. Zhang, Yan, Schöttker, Ben, Ordóñez-Mena, José, Butterbach, Katja, Brenner, Hermann. 2015. F2RL3 methylation, lung cancer incidence and mortality. In International journal of cancer, 137, 1739-48. doi:10.1002/ijc.29537. https://pubmed.ncbi.nlm.nih.gov/25821117/
5. Su, Qi, Shen, Gufeng, Xu, Guokang. . Strong correlation between F2RL3 in the blood and osteoarthritis based on a retrospective cohort study. In Medicine, 102, e33657. doi:10.1097/MD.0000000000033657. https://pubmed.ncbi.nlm.nih.gov/37233402/